The global antiseptics and disinfectants market size was USD 19.15 Billion in 2020 and is expected to register a revenue CAGR of 6.6% during the forecast period. Increasing use of antiseptics & disinfectants in hospitals and healthcare settings for topical and hard-surface applications, rising adoption of antiseptics & disinfectants among people amid COVID-19 pandemic, and growing use of antiseptics agents in dermatologic surgical procedures by healthcare providers are key factors expected to drive antiseptics & disinfectants market revenue growth over the forecast period. Antiseptics and disinfectants are being adopted for routine use to prevent hospital-acquired infections and have been of paramount importance in maintaining patient safety and lowering the rate of hospital-associated infections. Disinfectants are majorly used in home premises and farms, in water treatment, and food processing facilities; whereas, antiseptics are used in soaps, dairy sanitizers, and to treat local infections. Increasing demand for antiseptics & disinfectants is expected to continue to drive revenue growth of the antiseptics & disinfectants market going ahead.
Disinfectants are classified as chemical agents that are used on hard surfaces or inanimate objects to neutralize known pathogens. Antiseptics are antimicrobial substances that are applied to the skin or mucous membranes to reduce growth of microbial flora, and are widely used in the healthcare sector to reduce transient microbial flora on hands of health care providers to reduce person-to-person transmission of microbes, prepare the skin of patients prior to invasive procedures, and achieve surgical hand antisepsis. Alcohols, chlorhexidine, cholorxylenol, and iodine and iodophors are some commonly used disinfectants and antiseptics. Increasing concerns regarding microbial contamination and infection risks in food and other such substances has led to rising adoption of antiseptics and disinfectants among individuals. Over the recent years, considerable progress has been made in understanding the mechanisms of antibacterial actions of antiseptics and disinfectants to ensure proper usage of these antiseptics & disinfectants according to the clinical requirement.
Request a Sample@ https://qyresearchmedical.com/sample/118930
Proper selection and use of antiseptics and disinfectants is crucial for prevention of nosocomial infection, whether the patient is undergoing a surgical procedure, has an implant, is on mechanical ventilator, or is hospitalized for other treatments. Extensive research & development have led to launch of new antiseptics and disinfectants that can overcome microbial resistance and minimize toxicity. Emergence of multidrug resistant and multidrug susceptible bacterial strains as pathogens of healthcare-associated infections is further boosting demand for stronger and novel antiseptics & disinfectants and is another key factor expected to contribute to revenue growth of the market going ahead. However, increasing incidence of hospital-acquired infections due to contaminated disinfectants & antiseptics and growing bacterial resistance to known disinfectants are key factors that could restrain market growth to a certain extent going ahead.
Driver: Growing need to control infections in hospital and other healthcare settings is a key factor driving market growth
Antiseptics & disinfectants are widely used to control infections as both these chemicals are extremely effective against a number of bacteria, viruses, and fungi. These chemicals are majorly used in hospitals and other clinical settings for various topical and hard-surface applications to prevent growth of pathogenic organisms and maintain a sterile environment. Medical professionals use antiseptics to ensure sterility and cleanliness of hand scrubs and rubs. Hospitals primarily use these products for bathrooms, blood spills, and food prep zones and for non-porous surfaces and non-critical devices. Antiseptics & disinfectants help hospitals and clinical care settings achieve a state or environment of safety and cleanliness by reducing microbial contamination on animate and inanimate objects to a level that does not facilitate transmission of pathogens from hard surfaces to healthcare workers or patients. Increasing incidence of hospital-acquired infections as well as infections caused due to contaminated antiseptics & disinfectants have further boosted demand for advanced chemical solutions that can prevent occurrence and reoccurrence of infections. In addition, growing need to prevent secondary infections during the COVID-19 pandemic has further boosted adoption of effective infection prevention control strategies and is among the major factors expected to fuel revenue growth of the antiseptics & disinfectants market going ahead.
Restraint: Adverse effects of antiseptic & disinfectant agents are factors restraining market growth
Prolonged exposure to disinfectants and antiseptics among healthcare workers have led to development of certain side effects such as sneezing, headache, skin rashes, and chronic cough. Increasing incidence of occupational hazards such as adverse reactions linked to extensive use of disinfectants is a major factor that can hamper market revenue growth to some extent. Higher concentrations of sodium hypochlorite can cause shortness of breath, nausea, chest pain, and irritation in the airways. In addition, certain research studies have demonstrated that using cleaning products weekly have led to increasing incidence of asthma and asthma-related symptoms, with symptoms worsening with increasing use of cleaning sprays. Throat irritation, obsessive compulsive disorder, headache, lack of concentration, dizziness, and extreme fatigue have also been reported as some of the adverse effects of disinfectants among general population. Proven adverse effects of methanol such as skin damage, blindness, poising, and death in severe cases have resulted in prohibition of using products for disinfection of body organs and surfaces while surgeries, and this is another factor that could restrain market revenue growth over the forecast period.
Based on type, the global antiseptics & disinfectants market has been segmented into chlorine compounds, quaternary ammonium compounds, and enzymes. Quaternary ammonium compounds segment is expected to account for largest revenue share over the forecast period attributable to extensive use of disinfectant products having quaternary ammonium compounds as active ingredients. Quaternary ammonium compounds have numerous advantages such as good stability and toxicology, surface activity, and compatibility with formulation ingredients and lack of odor which make it well-suited for consumer products that combine cleaning with disinfection.
Quaternary ammonium compounds are described as low-level disinfectants by U.S. CDC and are effective against most vegetative bacteria, enveloped viruses, and certain fungi. Quaternary ammonium compounds are commonly used disinfectants in the food industry as these are very stable, unaffected by pH levels, and are effective on food-contact surface for a longer time. QACs have also been widely used for a variety of clinical applications such as preoperative disinfection of unbroken skin, disinfection of noncritical surfaces, and application to mucous membranes. These are key factors driving revenue growth of the segment.
Product Type Outlook:
Based on product type, the global antiseptics & disinfectants market has been segmented into medical device disinfectants, enzymatic cleaners, and surface disinfectants. Medical device disinfectants segment is expected to register a significantly high revenue growth rate over the forecast period owing to increasing application of disinfectants in reprocessing or disinfection of medical devices. Decontamination and reprocessing of medical devices is a crucial process of saving lives of patients, protecting healthcare workers, and reducing the rate of hospital-acquired infections. Antiseptics and disinfectants are an integral part of infection control practices and aid in preventing nosocomial infections and growing focus on Infection Prevention and Control (IPC) have further increased product use to disinfect and sterilize medical devices.
Growing outbreaks of epidemics and increasing awareness regarding spread of microbial resistance have further led to implementation of required infrastructure and standard procedures for effective sterilization and decontamination reprocessing of medical devices. For instance, healthcare associated infections occur in over 2 Million patients annually in the United States with development of biofilms on the surface of medical equipment. This has further boosted use of disinfectants in decontamination of medical devices to prevent transmission of infectious pathogens from contaminated surfaces and medical equipment to patients and is another key factor expected to fuel revenue growth of this segment.
Based on end-use, the global antiseptics & disinfectants market has been segmented into hospitals and clinics. Hospitals segment is expected to register a robust revenue CAGR over the forecast period attributable to increasing use of disinfectants as a primary intervention mode against pathogens in healthcare facilities. Antiseptics and disinfectants play a crucial role in microbial control in hospitals and are commonly used in automated machines that are designed to sterilize medical equipment such as endoscopes and dental instruments, among others.
Regular use of disinfection minimizes the risk of healthcare-associated infections (HAIs) and the product has become increasingly important in multi-barrier approach in preventing infections. Selection of appropriate disinfectants and antiseptics and adequate knowledge among hospital staff regarding use of disinfectants has further boosted product adoption. Proper use of disinfecting agents and effective sterilization can ensure safety of invasive and noninvasive medical devices and prevent hospital-acquired infections or risk to patients. This is another key factor expected to boost revenue growth of the segment over the forecast period.
Based on regional analysis, North America market is expected to account for largest revenue share in the global market over the forecast period attributable to increasing implementation of proper infection control strategies owing to growing cases of hospital-acquired infections in countries in the region, rising number of surgeries and invasive procedures performed, and increasing awareness among individuals and healthcare facilities regarding benefits and importance of routine disinfection processes. In addition, growing focus on home disinfection and robust presence of key manufacturers are some other factors expected to contribute to revenue growth of the market in North America.
Asia Pacific market is expected to register a robust revenue CAGR of 7.8% owing to increasing adoption disinfectants and antiseptics to maintain cleanliness at homes, hospitals, and in the food industry, growing availability of robust disinfecting agents, growing adoption of cleaning services owing to increasing disposable income among individuals, and rising need to prevent healthcare-associated infections and food poisoning.
The global antiseptics & disinfectants market is highly fragmented with presence of large number of players operating on a global and regional scale. Key players are engaged in product development and strategic alliances to cater to growing global demand and gain a robust footing in the market. Major companies profiled in the global market report include Reckitt Benckiser Group plc. Kimberly-Clark Corporation, Cardinal Health, Johnson & Johnson, 3M, STERIS Plc, Bio-Cide International, Inc., Novartis AG, Becton, Dickinson and Company, and Nufarm Limited.
Strategic Developments in the Market include:
- In August 2021, Aurabeat, which is a Hong-Kong- based company, launched U.S. FDA-approved Anti-COVID disinfectant technology for the market in India. The anti-COVID class 2 medical device for SARS-CoV-2 disinfection is the company’s step towards fight against the pandemic and can be used to clean offices, colleges, schools, and restaurants, among others.
- In September 2021, Novo Nordisk Pharmatech A/S announced a strategic partnership with HELM de Mexico for commercialization and distribution of pharmaceutical grade-QACs to the Mexican healthcare industry.
Australian Register of Therapeutic Goods (ARTG) recently granted approval to Nanocyn Disinfectant & Sanitizer developed by MicroSafe Care Australia and manufactured by Sonoma Pharmaceuticals, Inc. for use against SARS-CoV-2. The disinfectant has a 30 second virucidal kill time on hard surfaces, which is a breakthrough time for a non-toxic disinfectant.
Efficiency of Chlorhexidine-alcohol solution versus povidone-iodine solution as antiseptic agents in preventing infections in external fixators was determined through a randomized clinical trial. The trial was performed at a Spanish Hospital in patients who had undergone placement of external fixator. The trial demonstrated equal efficiency of both the antiseptics in preventing pin-site infection.
Another key development includes the U.S. FDA approvedal for expanded reprocessing procedures developed by UVision 360, Inc. for use with LUMINELLE DTx System and includes approval for Steris Revital-Ox RESERT HLD as a high-level disinfectant and Steris V-PRO Low Temperature Sterilization method that can be extensively used in hospitals and outpatient surgical centers.
Segments Covered in the Report:
This report offers historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of the market trends in each of the sub-segments from 2019 to 2030. For the purpose of this report, Reports and Data has segmented the global antiseptics & disinfectants market based on type, product type, end-use, and region:
Antiseptics and Disinfectants Market Report Scope
Segments covered By Type Outlook, Product Type Outlook , End-Use Outlook, Regional Outlook
By Type Outlook
Quaternary Ammonium Compounds
Alcohols & Aldehyde Products
By Product Type Outlook
Medical Device Disinfectants
By End-Use Outlook
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/118930/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: